tradingkey.logo

Ekso Bionics Holdings Inc

EKSO
View Detailed Chart
10.410USD
+1.050+11.22%
Close 02/06, 16:00ETQuotes delayed by 15 min
27.31MMarket Cap
LossP/E TTM

Ekso Bionics Holdings Inc

10.410
+1.050+11.22%
Intraday
1m
30m
1h
D
W
M
D

Today

+11.22%

5 Days

+19.66%

1 Month

+9.23%

6 Months

+220.31%

Year to Date

+20.49%

1 Year

+28.40%

View Detailed Chart

Key Insights

Ekso Bionics Holdings Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 82 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.50.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Ekso Bionics Holdings Inc's Score

Industry at a Glance

Industry Ranking
82 / 205
Overall Ranking
221 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Ekso Bionics Holdings Inc Highlights

StrengthsRisks
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 38.82% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 17.93M.
Undervalued
The company’s latest PE is -1.92, at a low 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 35.45K shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
9.500
Target Price
+1.50%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Ekso Bionics Holdings Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Ekso Bionics Holdings Inc Info

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
Ticker SymbolEKSO
CompanyEkso Bionics Holdings Inc
CEODavis (Scott G)
Websitehttps://eksobionics.com/
KeyAI